Skip to main content

Fate Therapeutics, Inc. - Common Stock (NQ: FATE )

1.600 -0.060 (-3.61%)
Streaming Delayed Price Updated: 9:58 AM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 03, 2018
Form 4
Source: SEC/Edgar
May 03, 2018
Form 4
Source: SEC/Edgar
May 03, 2018
Form 4
Source: SEC/Edgar
May 03, 2018
Form 4
Source: SEC/Edgar
May 03, 2018
Form 3
Source: SEC/Edgar
December 18, 2017
Form 4
Source: SEC/Edgar
October 16, 2017
Form 4
Source: SEC/Edgar
October 16, 2017
Form 4
Source: SEC/Edgar
October 16, 2017
Form 4
Source: SEC/Edgar
January 05, 2017
Form 4
Source: SEC/Edgar
January 05, 2017
Form 4
Source: SEC/Edgar
January 05, 2017
Form 4
Source: SEC/Edgar
January 05, 2017
Form 4
Source: SEC/Edgar
January 05, 2017
Form 4
Source: SEC/Edgar
November 27, 2016
Form 4
Source: SEC/Edgar
November 27, 2016
Form 4
Source: SEC/Edgar
November 27, 2016
Form 4
Source: SEC/Edgar
August 23, 2016
Form 4
Source: SEC/Edgar
May 17, 2016
Form 3
Source: SEC/Edgar
May 17, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
May 12, 2016
Form 4
Source: SEC/Edgar
January 19, 2016
Form 4
Source: SEC/Edgar
January 13, 2016
Form 4
Source: SEC/Edgar
January 11, 2016
Form 4
Source: SEC/Edgar
January 11, 2016
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.